 |
| Nathan Rich |
Elevance Health, the big Indianapolis-based healthcare insurer formerly known as Anthem, has hired Nathan Rich as VP-investor relations, effective Nov. 11.
He succeeds Stephen Tanal, who is now CFO for Elevance’s government health benefits unit.
Rich joins Elevance from Goldman Sachs, where he served as a VP in its global investment research operation during a 12-year run.
He also spent seven years as a sell-side research analyst at Citibank, and was a financial planning analyst at Ameriprise Financial Services for two years.
At Elevance, Rich reports to Mark Kaye, EVP & CFO. He cited Rich's extensive experience in the managed care, healthcare services and consumer sector.
“His diverse expertise, coupled with his analytical acumen will be instrumental in driving our strategy forward as we continue to evolve as a lifetime trusted health partner,” said Kaye.
Elevance chalked up a 5.3 percent hike in Q3 revenues to $44.7B. Net income slid 22.5 percent to $1B due to “unprecedented challenges in the Medicaid business,” according to CEO Gail Boudreaux.
To negotiate the demands of media, investors, regulators and the market, communicators to make sure that their narrative they construct is defensible every stop of the way.
In a health landscape crowded with claims, brands earn trust by pairing credible proof with human stories, cultural relevance, and empowerment.
Binaytara, the Bellevue, WA-based nonprofit dedicated to improving access to cancer care and fostering scientific research, has appointed FINN Partners as its global PR firm.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
